Anthranilic Acid

Anthranilic Acid

SCHEMBL7870197

Cc1onc(-c2c(F)cccc2Cl)c1C(=O)Cl.Nc1ccccc1C(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.62
ALDH1A1 P00352 2/20 0.58
KMT2A Q03164 4/20 0.57
MEN1 O00255 2/20 0.57
SMN1; SMN2 Q16637 3/20 0.54
GPBAR1 Q8TDU6 1/20 0.53
KDM4E B2RXH2 2/20 0.52
PPARG P37231 1/20 0.52
NCOA2 Q15596 1/20 0.52
GAA P10253 3/20 0.52
MAPT P10636 2/20 0.52
ATM Q13315 3/20 0.52
GLA P06280 1/20 0.52
HPGD P15428 1/20 0.52
HTT P42858 1/20 0.52
TSHR P16473 1/20 0.51
PTGS2 P35354 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30881266 0.87 LMNA (0.68) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL1065677 0.87 LMNA (0.68) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL899628 0.82 LMNA (0.68) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL6644159 0.79 LMNA (0.56) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7184918 0.78 TSHR (0.82) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL3451560 0.78 TSHR (0.75) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL10520781 0.77 LMNA (0.68) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL10332625 0.76 LMNA (0.67) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL5774615 0.76 LMNA (0.59) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL6642289 0.75 KDM4E (0.54) LMNAALDH1A1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1067928-A4 METHODS FOR INHIBITING MRP1 LILLY CO ELI (US) 2001-11-14 EP disclosed
EP-1067928-A1 METHODS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 2001-01-17 EP disclosed
WO-1999051228-A1 METHODS FOR INHIBITING MRP1 ELI LILLY AND COMPANY (US) 1999-10-14 WO disclosed